<?xml version="1.0" encoding="utf-8"?>
<!-- Generator: Adobe Illustrator 26.3.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
	 viewBox="0 0 1877 1401.7" style="enable-background:new 0 0 1877 1401.7;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#4D4D4F;}
	.st1{font-family:'TradeGothicLTStd';}
	.st2{font-size:23px;}
	.st3{font-size:13.416px;}
	.st4{fill:#007A33;}
	.st5{font-family:'TradeGothicLTStd-Bold';}
	.st6{font-size:52px;}
	.st7{font-size:30.332px;}
	.st8{font-family:'TradeGothicLTStd-Bd2';}
	.st9{font-size:32px;}
	.st10{font-size:18.666px;}
	.st11{opacity:0.831;}
	.st12{fill:#FFFFFF;}
	.st13{fill:none;stroke:#BBBCBC;}
	.st14{fill:none;stroke:#FFFFFF;}
	.st15{font-size:30px;}
	.st16{font-size:31px;}
	.st17{font-size:25px;}
	.st18{font-size:18.082px;}
</style>
<g>
	<text transform="matrix(1 0 0 1 1424 647)" class="st0 st1 st2">CKD, chronic kidney disease; DD,</text>
	<text transform="matrix(1 0 0 1 1424 681)" class="st0 st1 st2">dialysis-dependent; ESA,</text>
	<text transform="matrix(1 0 0 1 1424 715)" class="st0 st1 st2">erythropoiesis-stimulating agent;</text>
	<text transform="matrix(1 0 0 1 1424 749)" class="st0 st1 st2">MedDRA, Medical Dictionary tor</text>
	<text transform="matrix(1 0 0 1 1424 783)" class="st0 st1 st2">Regulatory Activities; NDD,</text>
	<text transform="matrix(1 0 0 1 1424 817)" class="st0 st1 st2">non-dialysis-dependent</text>
	<text transform="matrix(1 0 0 1 1424 447)" class="st0 st1 st2">*Associated with CKD patients who were</text>
	<text transform="matrix(1 0 0 1 1424 481)" class="st0 st1 st2">on dialysis while receiving EVRENZO.</text>
	<text transform="matrix(1 0 0 1 1424 539.3341)" class="st0 st1 st3">†</text>
	<text transform="matrix(1 0 0 1 1430.708 547)" class="st0 st1 st2">Based on global post-marketing</text>
	<text transform="matrix(1 0 0 1 1424 581)" class="st0 st1 st2">experience.</text>
	<text transform="matrix(1 0 0 1 1424 883)" class="st0 st1 st2">1. EVRENZO EU SmPC, September 2022.</text>
</g>
<text transform="matrix(1 0 0 1 0 117)" class="st4 st5 st6">The safety profile of EVRENZO was</text>
<text transform="matrix(1 0 0 1 0 171)" class="st4 st5 st6">evaluated in over 6,800 patients</text>
<text transform="matrix(1 0 0 1 699.2411 153.6684)" class="st4 st5 st7">1</text>
<text transform="matrix(1 0 0 1 0 346)" class="st0 st8 st9">Adverse reactions observed during clinical studies</text>
<text transform="matrix(1 0 0 1 695.9297 335.3344)" class="st0 st8 st10">1</text>
<text transform="matrix(1 0 0 1 0 390)" class="st0 st1 st9">(very common ≥1/10; common ≥1/100 to &lt;1/10; uncommon ≥1/1,000 to &lt;1/100)</text>
<g transform="translate(0 430)">
	<path class="st4" d="M0,0h1359.6v75.8H0V0z"/>
	<g class="st11">
		<path class="st12" d="M0,74.2h1359.6v75.8H0V74.2z"/>
		<path class="st13" d="M0.5,74.7h1358.6v74.8H0.5V74.7z"/>
	</g>
	<g class="st11">
		<path class="st12" d="M0,148.4h1359.6v75.8H0V148.4z"/>
		<path class="st13" d="M0.5,148.9h1358.6v74.8H0.5V148.9z"/>
	</g>
	<path class="st13" d="M610.8,74.2v150.2"/>
	<path class="st14" d="M611.3,0.3v74.2"/>
	<text transform="matrix(1 0 0 1 17.973 120.24)" class="st0 st1 st15">Infections and infestations</text>
	<text transform="matrix(1 0 0 1 17.973 193.654)" class="st0 st1 st15">Metabolism and nutrition disorders </text>
	<path class="st13" d="M933.3,74.2v150.2"/>
	<text transform="matrix(1 0 0 1 653.568 120.24)" class="st0 st1 st15">Common</text>
	<text transform="matrix(1 0 0 1 652.168 194.474)" class="st0 st1 st16">Very common</text>
	<text transform="matrix(1 0 0 1 652.168 45.143)" class="st12 st8 st16">Frequency</text>
	<text transform="matrix(1 0 0 1 17.973 45.323)" class="st12 st8 st16">MedDRA System organ class (SOC) </text>
	<text transform="matrix(1 0 0 1 961.762 120.24)" class="st0 st1 st15">Sepsis</text>
	<text transform="matrix(1 0 0 1 961.762 193.654)" class="st0 st1 st15">Hyperkalaemia</text>
	<text transform="matrix(1 0 0 1 961.762 44.323)" class="st12 st8 st15">Adverse reaction</text>
	<path class="st14" d="M933.3,0.3v74.2"/>
	<g class="st11">
		<path class="st12" d="M0,222.7h1359.6v75.8H0V222.7z"/>
		<path class="st13" d="M0.5,223.2h1358.6V298H0.5V223.2z"/>
	</g>
	<g class="st11">
		<path class="st12" d="M0,296.9h1359.6v75.8H0V296.9z"/>
		<path class="st13" d="M0.5,297.4h1358.6v74.8H0.5V297.4z"/>
	</g>
	<path class="st13" d="M610.8,222.6v150.2"/>
	<text transform="matrix(1 0 0 1 17.973 268.719)" class="st0 st1 st15">Psychiatric disorders </text>
	<text transform="matrix(1 0 0 1 17.973 344.595)" class="st0 st1 st15">Nervous system disorders</text>
	<path class="st13" d="M933.3,222.6v150.2"/>
	<g>
		<text transform="matrix(1 0 0 1 653.568 268.719)" class="st0 st1 st15">Common</text>
		<text transform="matrix(1 0 0 1 653.568 344.595)" class="st0 st1 st15">Common</text>
		<text transform="matrix(1 0 0 1 961.762 268.719)" class="st0 st1 st15">Insomnia</text>
		<text transform="matrix(1 0 0 1 961.762 344.595)" class="st0 st1 st15">Seizures, headache</text>
	</g>
	<g class="st11">
		<path class="st12" d="M0,372.1h1359.6v151H0V372.1z"/>
		<path class="st13" d="M0.5,372.6h1358.6v150H0.5V372.6z"/>
	</g>
	<path class="st13" d="M610.8,372.8V523"/>
	<text transform="matrix(1 0 0 1 17.973 418.094)" class="st0 st1 st15">Vascular disorders</text>
	<path class="st13" d="M933.3,372.8V523"/>
	<text transform="matrix(1 0 0 1 653.568 419.735)" class="st0 st1 st16">Very common </text>
	<text transform="matrix(1 0 0 1 653.568 491.509)" class="st0 st1 st15">Common</text>
	<text transform="matrix(1 0 0 1 961.762 419.094)" class="st0 st1 st16">Hypertension, vascular</text>
	<text transform="matrix(1 0 0 1 961.762 450.094)" class="st0 st1 st16">access thrombosis (VAT)*</text>
	<text transform="matrix(1 0 0 1 961.762 490.688)" class="st0 st1 st15">Deep vein thrombosis (DVT)</text>
</g>
<text transform="matrix(1 0 0 1 0 239)" class="st0 st1 st9">Adverse events listed in the SmPC were derived from the whole ALPINE programme, including trials in NDD patients vs. placebo</text>
<text transform="matrix(1 0 0 1 0 283)" class="st0 st1 st9">or vs. ESA, as well as trials in DD patients vs. ESA</text>
<text transform="matrix(1 0 0 1 703.6694 272.3344)" class="st0 st1 st10">1</text>
<text transform="matrix(1 0 0 1 1591.75 95)" class="st0 st8 st17">EVRENZO (roxadustat)</text>
<text transform="matrix(1 0 0 1 1553.2 125)" class="st0 st8 st17">IS NOT APPROVED FOR USE</text>
<text transform="matrix(1 0 0 1 1578.55 155)" class="st0 st8 st17">IN THE UNITED STATES</text>
<text transform="matrix(1 0 0 1 1561.175 19)" class="st0 st8 st17">This information is intended</text>
<text transform="matrix(1 0 0 1 1565.35 49)" class="st0 st8 st17">for international audiences.</text>
<g transform="translate(0 878.868)">
	<g>
		<g class="st11">
			<path class="st12" d="M0,74.2h1359.6v150.1H0V74.2z"/>
			<path class="st13" d="M0.5,74.7h1358.6v149.1H0.5V74.7z"/>
		</g>
		<g class="st11">
			<path class="st12" d="M0,371.9h1359.6v75.8H0V371.9z"/>
			<path class="st13" d="M0.5,372.4h1358.6v74.8H0.5V372.4z"/>
		</g>
		<g class="st11">
			<path class="st12" d="M0,447h1359.6v75.8H0V447z"/>
			<path class="st13" d="M0.5,447.5h1358.6v74.8H0.5V447.5z"/>
		</g>
		<path class="st13" d="M610.8,74.2v150.2"/>
	</g>
	<text transform="matrix(1 0 0 1 14.588 119.395)" class="st0 st1 st15">Gastrointestinal disorders</text>
	<path class="st13" d="M933.3,74.2v150.2"/>
	<text transform="matrix(1 0 0 1 653.567 121.06)" class="st0 st1 st16">Very common </text>
	<text transform="matrix(1 0 0 1 652.168 193.654)" class="st0 st1 st15">Common</text>
	<text transform="matrix(1 0 0 1 961.761 120.24)" class="st0 st1 st15">Nausea, diarrhoea</text>
	<text transform="matrix(1 0 0 1 961.761 193.654)" class="st0 st1 st15">Constipation, vomiting</text>
	<g class="st11">
		<path class="st12" d="M0,222.7h1359.6v75.8H0V222.7z"/>
		<path class="st13" d="M0.5,223.2h1358.6V298H0.5V223.2z"/>
	</g>
	<g class="st11">
		<path class="st12" d="M0,296.9h1359.6v75.8H0V296.9z"/>
		<path class="st13" d="M0.5,297.4h1358.6v74.8H0.5V297.4z"/>
	</g>
	<path class="st13" d="M610.8,222.6v150.2"/>
	<text transform="matrix(1 0 0 1 14.588 344.5939)" class="st0 st1 st15">Hepatobiliary disorders </text>
	<text transform="matrix(1 0 0 1 14.588 266.626)" class="st0 st1 st15">Skin and subcutaneous tissue disorders</text>
	<text transform="matrix(1 0 0 1 14.588 420.47)" class="st0 st1 st15">Respiratory, thoracic, mediastinal disorders</text>
	<path class="st13" d="M933.3,222.6v150.2"/>
	<text transform="matrix(1 0 0 1 653.567 343.564)" class="st0 st1 st16">Uncommon</text>
	<text transform="matrix(1 0 0 1 653.567 421.29)" class="st0 st1 st16">Uncommon</text>
	<text transform="matrix(1 0 0 1 961.761 344.5939)" class="st0 st1 st15">Hyperbilirubinaemia</text>
	<text transform="matrix(1 0 0 1 961.761 420.47)" class="st0 st1 st15">Pulmonary embolism </text>
	<path class="st13" d="M610.8,372.8v150"/>
	<text transform="matrix(1 0 0 1 14.588 479.6149)" class="st0 st1 st16">General disorders and administration</text>
	<text transform="matrix(1 0 0 1 14.588 510.6149)" class="st0 st1 st16">site conditions </text>
	<path class="st13" d="M933.3,372.8v150"/>
	<text transform="matrix(1 0 0 1 652.168 493.884)" class="st0 st1 st16">Very common </text>
	<text transform="matrix(1 0 0 1 961.761 493.884)" class="st0 st1 st15">Peripheral oedema</text>
	<text transform="matrix(1 0 0 1 652.168 270.547)" class="st0 st1 st16">Not known</text>
	<text transform="matrix(1 0 0 1 795.9758 260.2147)" class="st0 st1 st18">†</text>
	<text transform="matrix(1 0 0 1 961.761 256.605)" class="st0 st1 st16">Dermatitis Exfoliative</text>
	<text transform="matrix(1 0 0 1 961.761 286.605)" class="st0 st1 st16">Generalised (DEG)  </text>
</g>
</svg>
